DDInter856 DDInter104
Unfractionated heparin (UH) is a heterogenous preparation of anionic, sulfated glycosaminoglycan polymers with weights ranging from 3000 to 30,000 Da. It is a naturally occurring anticoagulant released from mast cells. It binds reversibly to antithrombin III (ATIII) and greatly accelerates the rate at which ATIII inactivates coagulation enzymes thrombin (factor IIa) and factor Xa. UH is different from low molecular weight heparin (LMWH) in the following ways: the average molecular weight of LMWH is about 4.5 kDa whereas it is 15 kDa for UH; UH requires continuous infusions; activated partial prothrombin time (aPTT) monitoring is required when using UH; and UH has a higher risk of bleeding and higher risk of osteoporosis in long term use. Unfractionated hepar
Antithrombin Alfa is a recombinant antithrombin , an anticoagulant, that is used for the prevention of thromboembolic events in patients that have hereditary deficiency of antithrombin in high risk situations.
Antithrombin Alfa {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Collagenase clostridium histolyticum
Antithrombin Alfa {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Niraparib
Antithrombin Alfa {u} may lead to a major life threatening interaction when taken with {v} Ibritumomab tiuxetan
Antithrombin Alfa {u} may lead to a major life threatening interaction when taken with {v} Betrixaban
Antithrombin Alfa may cause a moderate interaction that could exacerbate diseases when taken with Collagenase clostridium histolyticum
Antithrombin Alfa may cause a moderate interaction that could exacerbate diseases when taken with Niraparib
Antithrombin Alfa may lead to a major life threatening interaction when taken with Ibritumomab tiuxetan
Antithrombin Alfa may lead to a major life threatening interaction when taken with Betrixaban